a public good project by the
Synthesis
Company
of California

© 2026

Mohamed F. Mohamed | doi.page

0 works0 citations0 h-index

Mohamed F. Mohamed

Virginia Department of Health(US)Virginia–Maryland College of Veterinary Medicine(US)Virginia Tech(US)

Publications by Year

Research Areas

Antimicrobial Peptides and Activities, RNA Interference and Gene Delivery, Biochemical and Structural Characterization, Antibiotic Resistance in Bacteria, Antimicrobial Resistance in Staphylococcus

Most-Cited Works

→ Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus(2016)273 cited
→ Dual Targeting of Intracellular Pathogenic Bacteria with a Cleavable Conjugate of Kanamycin and an Antibacterial Cell-Penetrating Peptide(2016)152 cited
→ Targeting Methicillin-Resistant Staphylococcus aureus with Short Salt-Resistant Synthetic Peptides(2014)106 cited
→ A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii(2017)102 cited
→ Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages(2017)73 cited
→ Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate(2017)56 cited

→ IL-10 Dysregulation Underlies Chemokine Insufficiency, Delayed Macrophage Response, and Impaired Healing in Diabetic Wounds(2021)

52 cited

→ Antibacterial Activity of Novel Cationic Peptides against Clinical Isolates of Multi-Drug Resistant Staphylococcus pseudintermedius from Infected Dogs(2014)45 cited

→ CrkII/Abl phosphorylation cascade is critical for NLRC4 inflammasome activity and is blocked by Pseudomonas aeruginosa ExoT(2022)39 cited

→ Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection(2014)38 cited